Inhibition of tau protein aggregation by rhodanine-based compounds

(Bentham Science Publishers) The design of tailored peptide-polymer conjugates as drug-specific formulation additives offers access to next generation precision additives that can render problematic small organic drugs water-soluble and improve bioavailability.